• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

ophthalmology

eyeball eye disease eyelash eyes
Marketing

EyePoint scopes out new commercial chief to prep Duravyu launch

EyePoint has tapped a new commercial leader with experience leading ophthalmology franchises at Genentech, Novartis and other firms.
Andrea Park Feb 18, 2026 7:00am
Astellas Pharma Izervay Partners in Protection campaign

Astellas Izervay campaign casts HCPs as 'Partners in Protection'

Feb 13, 2026 11:57am
Lenz Therapeutics Sarah Jessica Parker x Vizz

Lenz ups Vizz visibility with Sarah Jessica Parker DTC campaign

Jan 14, 2026 11:37am
Astellas Pharma Izervay campaign Babs Costello

Astellas taps Babs Costello to promote Izervay for GA

Oct 23, 2025 2:31pm
Ocular Therapeutixs old logo top and new logo bottom

Ocular Therapeutix sharpens focus with retina-centric rebrand

Jun 27, 2025 10:05am
Earnings chart

Apellis' weak quarter could signal Syfovre 'nadir': analysts

Nov 5, 2024 3:41pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings